We’re thrilled to announce @MarkVeich as PICI’s Chief Organizational Advancement Officer. Mark brings philanthropic and venture expertise that will support our mission to develop and deliver breakthrough cancer therapies. Join us in welcoming Mark to PICI! https://t.co/q6YOGjpXu6

We’re thrilled to celebrate @DrKarenKnudsen on being named a @FierceHealth 2025 Women of Influence honoree! At PICI, we work to develop breakthrough therapies to convert all cancers into curable diseases. Karen’s leadership drives that vision forward. https://t.co/jWGVEE92wz

Congrats to Carl June, Director of PICI Center @Penn, and PICI Collaborator Michel Sadelain of @Columbia, for the @BroermannAward. This honor recognizes Carl and Michel's trailblazing work in developing personalized cancer immunotherapy. Read more:

This week, we are excited to join @WCM_MeyerCancer at the 2025 PICI - Weill Cornell Medicine Research Symposium, where researchers and leaders will discuss the latest in cancer immunotherapy, and share insights on adoptive cell therapy and checkpoint blockade.

More than two decades after FOXP3 was found to be key in immune balance, a discovery behind this year’s #NobelPrize, Alex Marson of @GladstoneInst @UCSF, & team reveal how it can be controlled, opening doors to new autoimmune & cancer therapies. Learn more: https://t.co/ZtveHMIdkF

Proud to see PICI’s President of Research Ira Mellman receive SITC ’s “most prestigious award” this morning for his pioneering work & making a notable impact on the field. After accepting, he shared his perspective on the Coming Renaissance of Cancer Immunotherapy. #SITC25

This week, @DrKarenKnudsen joined a panel at @MilkenInstitute #MIHealthSummit, on the importance of scientific research & shared how PICI is helping the cancer immunotherapy field continue to thrive amidst uncertainty. #PICIatMIHealthSummit

At the @MilkenInstitute #MIHealthSummit, @DrKarenKnudsen spoke with industry leaders about the ways the research community can adapt and continue momentum amidst uncertainty and funding cuts. Watch the session: https://t.co/6TP9QfbJeO #PICIatMIHealthSummit

The PICI network will be showing up in force at this week’s #SITC25 Annual Meeting to showcase the latest advances in #immunotherapy. Read more: https://t.co/O56kRUCOf9

Congrats to PICI researcher Dr. @j_eyquem on the launch of Azalea Therapeutics! His PICI-supported work laid the foundation for Azalea’s approach to engineer therapeutic cells inside the patient: transforming cell and gene therapy. https://t.co/aHHnlAvhxT #PICI

In the final PICI #BCAM Research Spotlight, learn how researchers at @UCSF are helping accelerate immunotherapies for patients with breast cancer. Read more: https://t.co/SPivdJbVyF

CAR-T therapies have revolutionized blood cancer treatment, but have yet to transform triple-negative breast cancer. In this PICI #BCAM Research Spotlight, discover research from @WeillCornell to bring the power of CAR-T to breast cancer. Learn more: https://t.co/knSoO7gf6H

In this PICI #BCAM Research Spotlight, we’re sharing research from PICI collaborator institution @MDAndersonNews, where Dr. Kenneth Hu is exploring how to overcome barriers to #immunotherapy effectiveness in breast cancer and beyond.

In today’s #BreastCancerAwarenessMonth spotlight, discover research from @StanfordMed on how immune pathways influence breast cancer metastasis. More here: https://t.co/2Dt7VdrVN3

Dr. Ira Mellman, President of Research at PICI, delivered a keynote at AACR-NCI-EORTC #Targets25 on the coming renaissance of cancer immunotherapy & how PICI is accelerating research for patients. Photo©2025 American Association for Cancer Research® (AACR)/Todd Buchanan

This #BCAM, PICI is spotlighting scientific advances across the PICI Network that accelerate #breast cancer #immunotherapies. Today we focus on cancer vaccine and next-gen immunotherapy research from @PennMedicine. More here: https://t.co/69933Md3rZ

October is #BCAM, and PICI is highlighting scientific advances in cancer immunotherapy across the PICI Network. Today’s spotlight is on @DanaFarber. See the carousel for more & read about DFCI here: https://t.co/HqBI2HR676

This week PICI & the Innovative Cancer Medicines partnership celebrate the launch of the first demonstration project to provide #immunotherapy to people with colorectal cancer in Nigeria, an important step toward ensuring longer-term access to innovative immunotherapies for all.

Congratulations to PICI Member Researcher Dr. Lili Yang of @UCLA and team for developing a potentially highly effective, readily available, and lower-cost CAR-NKT #celltherapy for patients with advanced triple-negative #breastcancer. Learn more here:

Congrats to PICI CEO @DrKarenKnudsen for being named one of @oncodaily’s 100 Most Influential Women in Oncology. This recognition honors women like Dr. Knudsen who are transforming oncology care and inspiring the next generation of female leaders.